Spodoptera frugiperda single cell suspension cell line in serum-

Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Insect cell – per se

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435384, 435387, C12N 500

Patent

active

061035262

ABSTRACT:
Disclosed and claimed is a new insect cell line, Sf900+, ATCC CRL-12579. The insect cell line was established from Lepidoptera, Noctuidae, Spodoptera frugiperda Sf-9 (ATCC CRL-1771) through multiple rounds of limiting dilution and selection in a serum-free insect medium supplemented with added human insulin. The insect cell line is useful in BEVS or as an adjuvant and has many characteristics and advantages. Also disclosed and claimed are recombinant proteins from recombinant baculovirus expression in insect cells such as Sf900+ cells, for instance, HA, NA, EPO, CD4, CEA, and thrombospondin.

REFERENCES:
Hink and Butz. In Vitro Cellular & Developmental Biology. 21(6). pp. 333-339, Jun. 1985.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Spodoptera frugiperda single cell suspension cell line in serum- does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Spodoptera frugiperda single cell suspension cell line in serum-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spodoptera frugiperda single cell suspension cell line in serum- will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2005507

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.